DRW Medical is an innovative medical device manufacturer of neonatal and pediatric products that address potentially harmful bedside occurrences. Our monitoring technology, the NAPA LP-15, provides clinicians with appropriate tools to properly monitor and manage critical CPAP and NHF therapies. Bubble CPAP: Specially designed to address preventable under- and over-pressure situations that typically go unnoticed and can lead to pneumothorax or desaturations due to disconnects from therapy. NHF: The NAPA monitor can provide critical information about measurable dynamic CPAP during NHF. This information helps clinicians appropriately titrate flow rates for optimal outcomes. Our newly FDA cleared product, EXSALTA, enables safe smart suctioning that removes secretions without desaturation or mucosal damage. EXSALTA is a revolutionary change in practice with advantages for the patient and the clinician. DRW Medical strives to develop unique products that enable clinicians to provide the highest standard of care for the most fragile patients.